Open AccessScreening for human immunodeficiency virus in inner city females with abnormal cervical cytology
Author(s) -
Jennings T. Scott,
Dottino Peter,
Sperling Rhoda,
Beddoe Ann Marie
Publication year - 1996
Publication title -
infectious diseases in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.656
H-Index - 48
eISSN - 1098-0997
pISSN - 1064-7449
DOI - 10.1002/(sici)1098-0997(1996)4:5<281::aid-idog7>3.0.co;2-0
Subject(s) - medicine , colposcopy , cytology , obstetrics , referral , gynecology , human immunodeficiency virus (hiv) , inner city , cervical cancer , immunology , cancer , pathology , family medicine , economic geography , economics
Objective This report evaluates the acceptance, results, and predictors of human immunodeficiency virus (HIV) infection in inner city women referred to a colposcopy clinic for abnormal cervical cytology. Methods HIV testing results of 1,908 inner city women referred for abnormal cervical cytology were analyzed retrospectively with respect to acceptance, race, ethnicity, Pap smear results, sexually transmitted diseases (STDs), HIV exposures, and final histologic findings. Results HIV testing was accepted by 50.4% of patients. Women who agreed to screening were significantly more likely to admit exposure to HIV or to be Hispanic, foreign‐born, or have a history of multiple STDs. Of those screened, 3.3% were found to be HIV seropositive. Although higher grades of referral Pap smears were noted in the women found to be HIV seropositive, final histologic findings were not different. The only predictors of unknown HIV seropositivity were admitted HIV exposure and external condyloma. Conclusions Fifty percent of inner city women of unknown HIV status referred for abnormal cervical cytology will accept HIV serotesting and 3.3% are found to be positive. Most HIV‐seropositive women can be detected based on either a history of exposure to HIV or the presence of external condyloma. Infect. Dis. Obstet. Gynecol. 4:281–286, 1996. © 1997 Wiley‐Liss, Inc.